Detalles de la búsqueda
1.
Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain.
Eur J Clin Invest;
52(6): e13771, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313009
2.
Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study.
Diabetes Obes Metab;
23(8): 1892-1901, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914401
3.
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).
Diabetes Obes Metab;
20(2): 448-452, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28736942
4.
Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes.
Diabetes Obes Metab;
20(12): 2821-2829, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29974618
5.
Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents.
Diabetes Obes Metab;
19(12): 1798-1804, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432746
6.
Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study.
Diabetes Res Clin Pract;
207: 111071, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38142748
7.
Accuracy of Two Continuous Glucose Monitoring Devices During Aerobic and High-Intensity Interval Training in Individuals with Type 1 Diabetes.
Diabetes Technol Ther;
26(6): 411-419, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215205
8.
Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes.
Diabetes Ther;
14(4): 723-736, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36847952
9.
Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain.
Endocrinol Diabetes Metab;
6(6): e451, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715339
10.
Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience.
Diabetes Care;
45(3): 650-658, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35061022
11.
Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
J Diabetes Complications;
35(3): 107828, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33436143
12.
Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers.
Endocrinol Diabetes Nutr (Engl Ed);
68(8): 557-566, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34872639
13.
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Diabetes Care;
42(6): 1147-1154, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30728224
14.
Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014.
Hum Vaccin Immunother;
13(11): 2606-2611, 2017 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28933622
15.
Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Diabetes Technol Ther;
19(6): 355-362, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28459603
16.
Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
J Diabetes Sci Technol;
11(6): 1089-1095, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28633537
17.
Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
Pharmacoeconomics;
24 Suppl 1: 49-59, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16800162
18.
A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.
Diabetes Technol Ther;
17(3): 194-202, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25347226
19.
[Dapagliflozin, the first SGLT-2 inhibitor in the treatment of type 2 diabetes]. / Dapagliflozina, el primer inhibidor SGLT 2 en el tratamiento de la diabetes tipo 2.
Med Clin (Barc);
141 Suppl 2: 36-43, 2013 Sep.
Artículo
en Español
| MEDLINE | ID: mdl-24444523
20.
Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
Diabetes Technol Ther;
14(11): 1043-52, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23003329